Grandeur Peak Global Advisors LLC bought a new position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 49,854 shares of the company’s stock, valued at approximately $954,000. Grandeur Peak Global Advisors LLC owned about 0.19% of OrthoPediatrics as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of the business. AIGH Capital Management LLC acquired a new position in OrthoPediatrics during the second quarter worth about $5,161,000. Wasatch Advisors LP lifted its stake in OrthoPediatrics by 56.6% in the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after purchasing an additional 186,357 shares in the last quarter. Roubaix Capital LLC lifted its stake in OrthoPediatrics by 23.8% in the 1st quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock worth $4,603,000 after purchasing an additional 55,724 shares in the last quarter. Granahan Investment Management LLC boosted its holdings in shares of OrthoPediatrics by 35.1% during the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock worth $14,231,000 after purchasing an additional 232,760 shares during the last quarter. Finally, AWM Investment Company Inc. acquired a new position in shares of OrthoPediatrics during the 2nd quarter worth approximately $4,537,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.
Key OrthoPediatrics News
Here are the key news stories impacting OrthoPediatrics this week:
- Positive Sentiment: OrthoPediatrics completed the full U.S. commercial launch of its 3P™ Pediatric Plating Platform® Hip System after more than 350 successful implantations during its limited release. The system expands the company’s pediatric trauma and deformity portfolio and could create a long-term revenue and market-share opportunity, though management did not provide specific financial guidance. 3P Pediatric Plating Platform Hip System launch
- Positive Sentiment: Analyst sentiment remains favorable. Piper Sandler raised its target to $25, Needham lifted its target to $35, and BTIG increased its target to $29, while maintaining positive ratings. MarketBeat data shows a “Moderate Buy” consensus with an average target of $26.44.
- Positive Sentiment: Recent quarterly results exceeded expectations: OrthoPediatrics reported a loss of $0.26 per share versus the estimated loss of $0.30, while revenue of $70.51 million surpassed the $68.21 million consensus estimate. BlackRock and other institutional investors also recently initiated or expanded positions.
- Neutral Sentiment: Reported short interest was listed at zero shares, but an invalid change figure makes the data unreliable and limits its usefulness for assessing short-selling pressure.
- Negative Sentiment: Director David R. Pelizzon and major shareholders associated with Squadron Capital and Jennifer N. Pritzker sold a combined 38,300 shares for approximately $943,302 across August 24–26, at prices ranging from $24.28 to $25.75. The sales reduced their position by roughly 0.56%, leaving ownership of about 6.86 million shares. While modest relative to their remaining stake, repeated insider selling may weigh on investor sentiment, particularly with the stock near its 52-week high. SEC insider transaction filing
Analyst Upgrades and Downgrades
Get Our Latest Research Report on KIDS
OrthoPediatrics Trading Down 3.0%
KIDS opened at $23.32 on Friday. OrthoPediatrics Corp. has a 52 week low of $14.42 and a 52 week high of $26.74. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. The business has a fifty day simple moving average of $21.32 and a 200-day simple moving average of $18.62. The firm has a market cap of $608.89 million, a P/E ratio of -13.88 and a beta of 0.98.
OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The firm had revenue of $70.51 million for the quarter, compared to the consensus estimate of $68.21 million. On average, equities analysts expect that OrthoPediatrics Corp. will post -1.14 earnings per share for the current year.
Insiders Place Their Bets
In other news, major shareholder Jennifer N. Pritzker sold 18,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $24.28, for a total value of $437,040.00. Following the completion of the transaction, the insider owned 6,863,464 shares of the company’s stock, valued at approximately $166,644,905.92. This trade represents a 0.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00. Following the completion of the transaction, the insider owned 6,863,464 shares of the company’s stock, valued at $166,644,905.92. This trade represents a 0.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 114,900 shares of company stock worth $2,829,906 over the last three months. Company insiders own 32.50% of the company’s stock.
OrthoPediatrics Company Profile
OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.
The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.
Featured Articles
- Five stocks we like better than OrthoPediatrics
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report).
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.
